Assyro AI

Orange Book product · Generic (ANDA)

FERRIC CITRATE

FERRIC CITRATE

Generic (ANDA)ANDA 212563TE ABRX TEVA PHARMS USA

At a glance

Mar 11, 2026

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 11, 2026

    3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

FERRIC CITRATE

Strength

EQ 210MG IRON

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 212563

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of FERRIC CITRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.